Locations:
Search
Working from home leads to more efficiency, job satisfaction for research coordinators
Primary results from the phase 3 ANDROMEDA study
Mutational pattern in MDS is not random, study finds
Will cancer vaccine boost immunotherapy’s efficacy?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
When to change treatment strategy
Durvalumab monotherapy appears safe and well-tolerated
Phase I study also reveals possible resistance mechanisms to HER2 antibodies
Encouraging clinical efficacy with no rise in adverse events
Surprising outcome differs from previous results
Study finds good hematologic response and rapid action
Advertisement
Advertisement